Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?

(2020) Association of helicobacter pylori with multiple sclerosis: Protective or risk factor? Current Journal of Neurology. pp. 59-66. ISSN 2717-011X

[img]
Preview
Text
13135.pdf

Download (267kB) | Preview

Abstract

Background: Multiple sclerosis (MS) is a common autoimmune inflammatory disease in the central nervous system (CNS) without exact pathology. Environmental factors such as infections have a causal or protective role in MS. Helicobacter pylori (HP) is one of the infections in digestive diseases and previous studies reported controversial findings of this infection role in MS. So, we conducted this study to assess the frequency of HP infection in patients with MS in comparison to the healthy population. Methods: This cross-sectional study was undertaken between 2015 and 2019. 191 participants including 58 patients with clinically isolated syndrome (CIS), 57 patients with relapsing-remitting MS (RRMS), 39 patients with secondary progressive MS (SPMS), and 39 age- and sex-matched healthy controls (HCs) were tested for the presence of HP immunoglobulin G (IgG) and IgM antibodies (Abs) in their serum sample. Results: The frequency of HP IgG seropositivity in patients with SPMS was significantly higher than patients with CIS Odds ratio (OR): 6.333, 95% confidence interval (CI): 2.522-15.906, P < 0.001, patients with RRMS (OR: 4.583, 95% CI: 1.842-11.407, P = 0.001), and HCs (OR: 8.485, 95% CI: 3.058-23.540, P < 0.001). We did not find a significant difference among other study groups regarding IgG seropositivity. No significant difference among groups regarding HP IgM seropositivity was evident. On univariate model, Expanded Disability Status Scale (EDSS) score (OR: 1.038, 95% CI: 1.038-1.460, P = 0.017) and SPMS (OR: 4.583, 95% CI: 1.842-11.407, P = 0.001) were predictor for HP IgG seropositivity. On multivariate model, only SPMS had higher risk for HP IgG seropositivity compared to RRMS (OR: 5.554, 95% CI: 1.327-23.253, P = 0.019). We did not find a significant association between clinical and demographic variables with HP IgM seropositivity. Conclusion: Based on our findings, progressive MS and HP infection may have association. Further longitudinal studies with large sample size are needed to determine the role of HP infection in MS.

Item Type: Article
Keywords: Multiple Sclerosis Helicobacter Pylori Clinically Isolated Syndrome Secondary Progressive Multiple Sclerosis Iran INFECTION ERADICATION DISEASE AUTOIMMUNITY
Subjects: QW Microbiology and Immunology > QW 1-300 Microbiology
WL Nervous System
WL Nervous System > WL 200-405 Central Nervous System. Disorders. Therapeutics
Divisions: Faculty of Medicine > Departments of Clinical Sciences > Department of Neurology
Isfahan Neurosciences Research Center
Page Range: pp. 59-66
Journal or Publication Title: Current Journal of Neurology
Journal Index: ISI
Volume: 19
Number: 2
Identification Number: https://doi.org/10.18502/cjn.v19i2.4942
ISSN: 2717-011X
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/13135

Actions (login required)

View Item View Item